IPhone 5 Offered as the Prize by MD247 on Facebook - FOX5 Vegas - KVVU

IPhone 5 Offered as the Prize by MD247 on Facebook

Posted:

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: MD247.COM

MD247 announced on Tuesday morning that it would continue its unique contest to build interest in telemedicine using the MD247 Facebook Business Page.

Tampa, FL (PRWEB) November 27, 2012

MD247 announced on Tuesday morning that it would continue its unique contest to build interest in telemedicine using the MD247 Facebook Business Page. The contest is a random drawing for either the highly popular iPhone 5, or the Samsung Galaxy S III, based upon the engagement of the readers. Each Facebook like, each Facebook reply and each Facebook share is a single contest entry for anyone who would like a chance to win either of the smart phones being offered.

Parties who are interested in participating in the MD247 random drawing for either phone should visit MD247 on Facebook at http://www.facebook.com/md247dotcom.

Seminole Florida based MD247 (MD 247; MD/247; M.D. 247; MD247.COM) provides discounted telemedicine healthcare services nationwide to families, and discounted wholesale telemedicine healthcare to businesses. MD247 has successfully provided 25,000 people the ability to chat with a doctor twenty-four hours a day, talk to a nurse twenty-four hours a day, receive discounted prescription drugs and receive discounted in-person healthcare services. In addition to discounted healthcare services, MD247 provides support to groups supporting the employment of veterans of the United States Armed Services. MD247 services, as well as informational blogs, can be found for review online at http://www.md247.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/11/prweb10174110.htm

Powered by WorldNow
Fox 5
Powered by WorldNow CNN
All content © 2013, KVVU Broadcasting Corporation, Las Vegas, NV and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.